Dermatology · Midland, MI
NPI
1568751931
Since 2011
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
2711 W Wackerly St
Midland, MI, 48640
Phone (989) 837-6868
Groups this clinician bills Medicare through
Medicare paid, 2024
$203K
4,106 services
Medicare patients, 2024
1,140
Average age 75
Drug cost, 2024
$3.7M
2,052 prescriptions
Company payments, 2025
$71K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Benjamin J Workman was code 17003 (destruction skin lesion), 1,177 times for 298 patients. In total Benjamin J Workman billed 4,106 services in 71 codes, and Medicare paid $203K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,177 | 298 | $4.36 | $5,134 |
| 99213 Office E&M - Established | Office | 778 | 653 | $58.10 | $45K |
| 17000 Destruction Skin Lesion | Office | 525 | 455 | $38.61 | $20K |
| 17110 Destruction Skin Lesion | Office | 193 | 178 | $76.44 | $15K |
| 11102 Skin Biopsy | Office | 180 | 165 | $60.06 | $11K |
| 99203 Office E&M - New | Office | 161 | 161 | $66.55 | $11K |
| 99212 Office E&M - Established | Office | 157 | 154 | $34.81 | $5,465 |
| 99202 Office E&M - New | Office | 59 | 59 | $41.62 | $2,456 |
| 11103 Skin Biopsy | Office | 28 | 24 | $32.38 | $907 |
| 17281 Destruction Skin Lesion | Office | 23 | 21 | $115.54 | $2,657 |
| 99214 Office E&M - Established | Office | 20 | 16 | $87.01 | $1,740 |
| 69100 Other Organ Systems | Office | 20 | 19 | $58.25 | $1,165 |
| 11900 Skin | Office | 19 | 14 | $30.11 | $572 |
| 12032 Wound Repair - All Levels | Office | 16 | 16 | $223.86 | $3,582 |
| 12051 Wound Repair - All Levels | Office | 14 | 14 | $195.49 | $2,737 |
By year: 2022 $153K for 3,760 services; 2023 $176K for 3,712 services; 2024 $203K for 4,106 services.
Medicare prescription drug claims, 2024
In 2024, the drug Benjamin J Workman prescribed most often to Medicare patients was Triamcinolone Acetonide, with 179 prescriptions and refills. In total Benjamin J Workman wrote 2,052 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 179 | 223 | 117 | $1,833 |
| Dupixent Pen Dupilumab | 153 | 157 | 17 | $628K |
| Doxycycline Hyclate Generic | 148 | 256 | 78 | $4,138 |
| Clobetasol Propionate Generic | 138 | 153 | 87 | $5,332 |
| Fluorouracil Generic | 135 | 142 | 124 | $8,299 |
| Ketoconazole Generic | 104 | 137 | 58 | $1,745 |
| Minoxidil Generic | 77 | 229 | 30 | $1,252 |
| Betamethasone Dipropionate Generic | 74 | 81 | 54 | $3,828 |
| Finasteride Generic | 62 | 186 | 21 | $676 |
| Skyrizi Pen Risankizumab-Rzaa | 59 | 153 | 18 | $1.2M |
| Fluocinonide Generic | 51 | 67 | 36 | $1,526 |
| Metronidazole Generic | 51 | 66 | 35 | $2,398 |
| Prednisone Generic | 48 | 74 | 29 | $200 |
| Hydroxychloroquine Sulfate Generic | 46 | 110 | 16 | $3,559 |
| Acitretin Generic | 46 | 99 | 12 | $19K |
Brand drugs: 424 claims; generic drugs: 1,628 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Benjamin J Workman $71K ($71K in general payments such as food, travel and fees) from 18 companies. The largest payer was Genzyme Corporation with $47K.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 40 | $47K |
| Janssen Biotech, Inc. JNJ | 35 | $22K |
| Abbvie Inc. ABBV | 24 | $308 |
| UCB, Inc. UCB.BR | 12 | $222 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 11 | $167 |
| Galderma Laboratories, L.P. GALD.SW | 18 | $150 |
| Amgen Inc. AMGN | 5 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $72.6 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $70.33 |
| Incyte Corporation INCY | 3 | $67.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.